Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 01:18PM ET
6.95
Dollar change
+0.01
Percentage change
0.22
%
IndexRUT P/E- EPS (ttm)-2.13 Insider Own57.90% Shs Outstand97.38M Perf Week-1.77%
Market Cap834.81M Forward P/E- EPS next Y-1.51 Insider Trans16.03% Shs Float50.54M Perf Month61.74%
Income-204.50M PEG- EPS next Q-0.39 Inst Own34.64% Short Float21.52% Perf Quarter-19.69%
Sales0.59M P/S1414.93 EPS this Y25.01% Inst Trans- Short Ratio14.44 Perf Half Y-3.54%
Book/sh2.03 P/B3.42 EPS next Y7.56% ROA-65.09% Short Interest10.88M Perf Year-47.51%
Cash/sh1.76 P/C3.96 EPS next 5Y- ROE-78.27% 52W Range4.11 - 17.20 Perf YTD-21.50%
Dividend Est.- P/FCF- EPS past 5Y-193.88% ROI-72.82% 52W High-59.56% Beta2.42
Dividend TTM- Quick Ratio8.91 Sales past 5Y-25.00% Gross Margin-1850.08% 52W Low69.22% ATR (14)0.57
Dividend Ex-DateSep 10, 2019 Current Ratio8.91 EPS Y/Y TTM-33.33% Oper. Margin-33773.27% RSI (14)57.87 Volatility9.18% 9.88%
Employees234 Debt/Eq0.18 Sales Y/Y TTM- Profit Margin-34601.86% Recom1.33 Target Price14.18
Option/ShortYes / Yes LT Debt/Eq0.15 EPS Q/Q0.97% Payout- Rel Volume0.81 Prev Close6.94
Sales Surprise-69.25% EPS Surprise3.28% Sales Q/Q- EarningsMay 10 BMO Avg Volume753.49K Price6.95
SMA2013.79% SMA5014.84% SMA200-13.97% Trades Volume371,693 Change0.22%
Date Action Analyst Rating Change Price Target Change
May-20-24Initiated H.C. Wainwright Buy $10
May-16-24Upgrade Citigroup Neutral → Buy $10
Apr-22-24Initiated Chardan Capital Markets Buy $17
Apr-08-24Initiated TD Cowen Buy
Apr-03-24Initiated Wedbush Outperform $12
Jan-16-24Downgrade Stifel Buy → Hold $18 → $9
Dec-08-23Initiated Citigroup Neutral $10
Oct-09-23Initiated BMO Capital Markets Outperform $19
Jul-31-23Initiated Guggenheim Buy $24
Apr-18-23Initiated Stifel Buy $18
May-20-24 09:32PM
09:33AM
May-17-24 06:27AM
06:15AM
May-16-24 07:14AM
09:55AM Loading…
May-14-24 09:55AM
May-13-24 11:12AM
08:00AM
May-12-24 03:00AM
May-10-24 02:23PM
01:53PM
08:00AM
May-08-24 08:00AM
May-03-24 12:00PM
May-01-24 08:00AM
06:01AM Loading…
Apr-30-24 06:01AM
Apr-29-24 10:12AM
07:35AM
07:33AM
07:00AM
Apr-23-24 08:00AM
Mar-27-24 08:45AM
Mar-14-24 02:44PM
Mar-01-24 02:00PM
08:00AM
Feb-29-24 03:02AM
Feb-28-24 08:00AM
Feb-20-24 04:01PM
Feb-14-24 11:50PM
04:05PM
08:00AM Loading…
Feb-01-24 08:00AM
Jan-25-24 08:00AM
Jan-09-24 06:21PM
Jan-05-24 05:00PM
08:00AM
Jan-02-24 08:00AM
Dec-19-23 10:30AM
Nov-30-23 07:45AM
Nov-08-23 08:00AM
Nov-03-23 04:01PM
Oct-30-23 03:46PM
Oct-27-23 06:00AM
Oct-24-23 07:30AM
05:04AM
Oct-23-23 02:50AM
Oct-17-23 08:00AM
Oct-09-23 09:33AM
Sep-19-23 08:00AM
Aug-31-23 08:00AM
Aug-07-23 04:01PM
Jul-25-23 07:45AM
Jun-29-23 08:46AM
Jun-22-23 08:00AM
Jun-02-23 10:15AM
May-31-23 08:00AM
May-26-23 09:45AM
May-17-23 04:05PM
06:00AM
May-11-23 08:00AM
Mar-27-23 08:00AM
Mar-09-23 08:00AM
Feb-27-23 08:00AM
Jan-20-23 05:56AM
Jan-09-23 07:00AM
Jan-03-23 08:00AM
Nov-01-22 04:13PM
Oct-24-22 05:30PM
Oct-20-22 12:45PM
Oct-19-22 09:47PM
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ARCH Venture Partners XII, LLC10% OwnerFeb 15 '24Buy6.253,200,00020,000,0003,200,000Feb 20 05:38 PM
ARCH Venture Partners X, LLC10% OwnerFeb 15 '24Buy6.253,200,00020,000,0003,200,000Feb 20 05:37 PM
NELSEN ROBERTDirectorFeb 15 '24Buy6.253,200,00020,000,0003,200,000Feb 20 05:41 PM
GV 2019 GP, L.L.C.10% OwnerJun 21 '23Sale14.9719,003284,4960Jun 22 05:03 PM
GV 2019 GP, L.L.C.10% OwnerJun 20 '23Sale15.0637,405563,2480Jun 22 05:03 PM
GV 2019 GP, L.L.C.10% OwnerJun 16 '23Sale15.026,53298,1090Jun 20 04:17 PM
GV 2019 GP, L.L.C.10% OwnerJun 15 '23Sale14.9266,659994,3260Jun 20 04:17 PM
GV 2019 GP, L.L.C.10% OwnerJun 14 '23Sale14.8728,960430,6840Jun 15 04:22 PM
GV 2019 GP, L.L.C.10% OwnerJun 13 '23Sale15.1328,100425,1020Jun 15 04:22 PM
GV 2019 GP, L.L.C.10% OwnerJun 12 '23Sale14.9816,031240,1510Jun 13 04:20 PM
GV 2019 GP, L.L.C.10% OwnerJun 09 '23Sale14.4815,672226,9840Jun 13 04:20 PM
GV 2019 GP, L.L.C.10% OwnerJun 08 '23Sale15.745,00078,6860Jun 09 04:24 PM
GV 2019 GP, L.L.C.10% OwnerJun 07 '23Sale16.9215,000253,8710Jun 09 04:24 PM
GV 2019 GP, L.L.C.10% OwnerJun 06 '23Sale17.0229,975510,1660Jun 07 04:17 PM
GV 2019 GP, L.L.C.10% OwnerJun 05 '23Sale16.7022,434374,6120Jun 07 04:17 PM
GV 2019 GP, L.L.C.10% OwnerJun 01 '23Sale14.3645,223649,1940Jun 02 04:17 PM
GV 2019 GP, L.L.C.10% OwnerMay 31 '23Sale13.6516,633227,0040Jun 02 04:17 PM
GV 2019 GP, L.L.C.10% OwnerMay 30 '23Sale13.7016,805230,2400May 31 04:15 PM
GV 2019 GP, L.L.C.10% OwnerMay 26 '23Sale13.7012,602172,6030May 31 04:15 PM
GV 2019 GP, L.L.C.10% OwnerMay 25 '23Sale13.3823,161309,9730May 26 04:17 PM